Statistics for Subcutaneous vs Intravenous Trastuzumab/Pertuzumab: A Time and Motion Substudy of a Phase II Trial of Adjuvant Trastuzumab/Pertuzumab for Stage I HER2+ Breast Cancer (ADEPT trial)

Total visits

views
Subcutaneous vs Intravenous Trastuzumab/Pertuzumab: A Time and Motion Substudy of a Phase II Trial of Adjuvant Trastuzumab/Pertuzumab for Stage I HER2+ Breast Cancer (ADEPT trial) 3

Total visits per month

views
January 2025 0
February 2025 0
March 2025 0
April 2025 2
May 2025 0
June 2025 1
July 2025 0

Top country views

views
United States 2
India 1

Top city views

views
Fishers 2
Jaipur 1